COVID-19 (coronavirus)

Shimada Lab

Personal Statement

Kenichi Shimada, PhD, has diverse scientific training in microbiology, immunology, molecular biology, lipid biochemistry and host-pathogen interactions. He completed his PhD studying how glycolipids of mycobacterium modulates the pathogenesis of mycobacterium infection and host responses. His postdoctoral research investigated the role of intracellular pathogen associated molecular patterns, Nod1/Nod2 and RIP2 in Chlamydia pneumoniae airway infection in the Arditi Laboratory. Shimada’s Chlamydia infection studies led to his recent seminal finding that oxidative mitochondrial DNA activates NLRP3 inflammasome. Research in the Shimada Lab is supported by NIH grants.


Kenichi Shimada, PhD

  • NLRP3 Inflammasome
  • Acute Lung Injury
Meet Our Team

Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Shimada Laboratory, whose dedicated efforts lead to groundbreaking discoveries.

Martinon D, Borges VF, Gomez AC, Shimada K.

Front Immunol. 2020 Jul 7;11:1623.

Noval Rivas M, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC, Fishbein MC, Chen S, Lehman TJ, Sato K, Shibuya A, Fasano A, Kiyono H, Abe M, Tatsumoto N, Yamashita M, Crother TR, Shimada K, Arditi M.

Immunity. 2019 Sep 17;51(3):508-521.e6.

Contact the Shimada Lab

8700 Beverly Blvd.
Davis Building, Room 4008
Los Angeles, CA 90048